Literature Review: Moving the Druggable Needle
The Use of an mRNA Display Technology and Affinity-Based Selection Is Used to Find Inhibitors to an Enzyme of Interest
To Surge or Not to Surge?
Experts Discuss Inclusion of a Surge Tank in an End-to-End Continuous Biomanufacturing Train
New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
- Olink Bioscience
- Dag Hammarskjöds väg 52B
- Uppsala , SE-752 37
Olink Bioscience is commercializing cutting-edge technologies for analysis of proteins and nucleic acids. These novel tools enable researchers to see further into biology revealing new insights into basic science, drug development, and diagnostics.